|
|
|
|
news.yahoo.com
--
1 hour, 2 minutes ago BOSTON (Reuters) - Wachovia Corp (WB.N), battered by mounting losses from mortgages and other debt and facing increasing regulatory scrutiny, is undertaking an independent review of its risk and compliance processes and cutting job..
Read More
|
|
|
news.yahoo.com
--
By Lisa Richwine Fri Jan 25, 7:23 PM ET WASHINGTON (Reuters) - U.S. regulators said on Friday they would review a study showing a Merck and Schering-Plough cholesterol drug worked no better than a generic in preventing the build-up of arterial plaque...
Read More
|
|
|
news.yahoo.com
--
By Lisa Richwine 23 minutes ago WASHINGTON (Reuters) - U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's (MRK.N) and Schering-Plough Corp's (SGP.N) popular cholesterol drug Vytorin after a study showed it was..
Read More
|
|
|
news.yahoo.com
--
By ADRIAN SAINZ, AP Business Writer 49 minutes ago MIAMI - Office Depot Inc. on Monday delayed its third-quarter earnings report due to its audit committee's independent review of vendor program funds, a development that one analyst said raised question..
Read More
|
|
|
news.yahoo.com
--
Thu Sep 20, 11:33 AM ET WASHINGTON (Reuters) - The head of the U.S. Senate Banking Committee said on Thursday that "careful review" is needed of the Nasdaq and Dubai stock exchange deal to ensure that there are no national security implications.
"As a..
Read More
|
|
